Century Therapeutics, Inc. SEC filings IPSC
Century Therapeutics, Inc. has 444 filings in SEC EDGAR's recent list, going back to Mar 15, 2021. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 2, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 16, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 12, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Other events
|
Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Results of operations
|
May 13, 2026 | May 13, 2026 |
| 8-K |
Current report
Other events
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jan 23, 2026 | Jan 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jan 8, 2026 | Jan 7, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 29, 2025 | Dec 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 12, 2025 | Dec 12, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 9, 2025 | Dec 9, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Listing notice
|
Aug 29, 2025 | Aug 27, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Aug 14, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change
|
Jul 7, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 19, 2025 | Mar 19, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 28, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Agreement ended
|
Dec 13, 2024 | Dec 12, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 5, 2024 | Nov 5, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 26, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Other events
|
Jul 8, 2024 | Jul 8, 2024 |
| 8-K/A | Amended current report | Jun 26, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Other events
|
Jun 3, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Acquisition or sale of assets, Unregistered share sale, Regulation FD disclosure
|
Apr 11, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Other events
|
Apr 11, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Other events
|
Apr 9, 2024 | Apr 8, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 14, 2024 | Mar 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 19, 2024 | Jan 15, 2024 |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 9, 2023 |
| 8-K |
Current report
Other events
|
Dec 6, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Officer or director change
|
Nov 14, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Other events
|
Oct 3, 2023 | Oct 3, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2023 | Aug 9, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 8-K/A |
Amended current report
Officer or director change
|
May 5, 2023 | Apr 11, 2023 |
| 8-K |
Current report
Agreement ended
|
May 5, 2023 | May 1, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 17, 2023 | Apr 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 20, 2023 | Mar 20, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 9, 2023 | Jan 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 30, 2022 | Nov 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Oct 3, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2022 | Sep 8, 2022 |
| 8-K |
Current report
Other events
|
Aug 25, 2022 | Aug 25, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2022 | Jul 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 13, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Results of operations
|
May 16, 2022 | May 16, 2022 |
| 8-K |
Current report
Other events
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Other events
|
Apr 13, 2022 | Apr 13, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2022 | Mar 17, 2022 |
| 8-K |
Current report
Material agreement
|
Jan 13, 2022 | Jan 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2022 | Jan 11, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jan 10, 2022 | Jan 7, 2022 |
| 8-K |
Current report
Other events
|
Dec 16, 2021 | Dec 16, 2021 |
| 8-K |
Current report
Other events
|
Nov 18, 2021 | Nov 18, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Other events
|
Oct 13, 2021 | Oct 13, 2021 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 25, 2021 | Jun 22, 2021 |
Showing 76 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IPSC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Philadelphia, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1850119
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.